These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 479368

  • 1. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI.
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [Abstract] [Full Text] [Related]

  • 2. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H, Ratnoff OD.
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM, Ram IE, Alderkamp GH, Bertina RM.
    Thromb Haemost; 1982 Aug 24; 48(1):54-8. PubMed ID: 6982540
    [Abstract] [Full Text] [Related]

  • 6. Biological control of factor VII.
    Nemerson Y.
    Thromb Haemost; 1976 Feb 29; 35(1):96-100. PubMed ID: 989197
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL, Pierce JV, Colman RW, Kaplan AP.
    J Clin Invest; 1977 Jul 29; 60(1):18-31. PubMed ID: 874082
    [Abstract] [Full Text] [Related]

  • 9. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H.
    J Clin Invest; 1977 Sep 29; 60(3):584-94. PubMed ID: 893664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD, Cochrane CG, Griffin JH.
    J Clin Invest; 1977 Jun 29; 59(6):1167-75. PubMed ID: 864009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC.
    Thromb Haemost; 1979 Jun 30; 41(4):756-73. PubMed ID: 483248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.